Pseudoephedrine Tablets
Natural health product licensed in Canada
- Licence holder
- Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
- NPN or DIN-HM
- 02010461
- Status
- Inactive licence
- Licence date
- 10 December 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium colloïdal, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | 6 years ; maximum: 11 years | 0.5 Comprimé | maximum: 4 Tous les jours |
| Enfants | minimum: 12 years | 1 Comprimé | maximum: 4 Tous les jours |
| Enfants | 2 years ; maximum: 5 years | 0.25 Comprimé | maximum: 4 Tous les jours |
| Enfants | maximum: 2 years | Not specified | Not specified |
| Adultes | minimum: 65 years | Not specified | Not specified |
| Adultes | Not specified | 1 Comprimé | maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To relieve nasal and sinus congestion due to colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Elderly person and those with high blood pressure, heart disease, diabetes, thyroid disease, glaucoma or difficulty in urination due to enlargement of the prostate should take this medication only on advice of a physician. If dizziness or confusion develops, do not drive or operate machinery. Do not take if you are currently taking or have recently taken Monoamine Oxidase (MAO) inhibitor drugs. Protect from light. Store between 15 C and 30 C. Cap is safety-sealed for your protection.
Source
Official Health Canada record, licence 02010461
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.